BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36464325)

  • 1. Identifying monoclonal gammopathy of undetermined significance from electronic health records.
    Tanenbaum HC; Birmann BM; Bertrand KA; Teras LR; Krishnan AY; Pourhassan H; Goldsmith S; Cannavale K; Wang SS; Chao CR
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1755. PubMed ID: 36464325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying monoclonal gammopathy of undetermined significance in electronic health data.
    Epstein MM; Saphirak C; Zhou Y; LeBlanc C; Rosmarin AG; Ash A; Singh S; Fisher K; Birmann BM; Gurwitz JH
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):69-76. PubMed ID: 31736189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
    Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
    Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Language Processing-Assisted Classification Models to Confirm Monoclonal Gammopathy of Undetermined Significance and Progression in Veterans' Electronic Health Records.
    Wang M; Yu YC; Liu L; Schoen MW; Kumar A; Vargo K; Colditz G; Thomas T; Chang SH
    JCO Clin Cancer Inform; 2023 Sep; 7():e2300081. PubMed ID: 38048516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
    Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.
    Wadhera RK; Kyle RA; Larson DR; Dispenzieri A; Kumar S; Lazarus HM; Rajkumar SV
    Blood; 2011 Sep; 118(11):2985-7. PubMed ID: 21765020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
    Kaur J; Valisekka SS; Hameed M; Bandi PS; Varma S; Onwughalu CJ; Ibrahim H; Mongia H
    Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):e195-e212. PubMed ID: 36966041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity in patients with monoclonal gammopathy of undetermined significance.
    Epstein MM; Zhou Y; Castaneda-Avila MA; Cohen HJ
    Int J Cancer; 2023 Jun; 152(12):2485-2492. PubMed ID: 36799553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
    Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
    Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.
    Sigurbergsdóttir AÝ; Rögnvaldsson S; Thorsteinsdóttir S; Sverrisdóttir I; Sigurðardóttir GÁ; Viðarsson B; Önundarson PT; Agnarsson BA; Sigurðardóttir M; Þorsteinsdóttir I; Ólafsson Í; Þórðardóttir ÁR; Gíslason GK; Ólafsson A; Hultcrantz M; Durie BGM; Harding S; Landgren O; Löve TJ; Kristinsson SY
    Haematologica; 2023 Dec; 108(12):3392-3398. PubMed ID: 37439374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance.
    Castañeda-Avila MA; Lapane KL; Person SD; Jesdale BM; Zhou Y; Mazor KM; Epstein MM
    Cancer Control; 2022; 29():10732748221126936. PubMed ID: 36112886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Gammopathy of Undetermined Significance.
    Gonsalves WI; Rajkumar SV
    Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Kyle RA; Rajkumar SV
    Oncology (Williston Park); 2011 Jun; 25(7):578-86. PubMed ID: 21888255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry.
    Gregersen H; Larsen CB; Haglund A; Mortensen R; Andersen NF; Nørgaard M
    Clin Epidemiol; 2013; 5():321-6. PubMed ID: 24009431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
    Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
    Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
    Seth S; Zanwar S; Vu L; Kapoor P
    Curr Hematol Malig Rep; 2020 Apr; 15(2):45-55. PubMed ID: 32222885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.